Literature DB >> 2056184

Human keratinocytes adhere to multiple distinct peptide sequences of laminin.

M S Wilke1, A P Skubitz.   

Abstract

In normal human skin, basal layer keratinocytes of the epidermis are intimately associated with the lamina lucida of the basement membrane. Laminin, which is an 850-kD glycoprotein that has a cruciform shape by rotary shadowing and electron microscopy, is localized to the lamina lucida. The present study was aimed at further characterizing the interaction between laminin and cultured human keratinocytes. Initial studies revealed that laminin-coated substrata significantly promoted keratinocyte attachment in a concentration-dependent manner. To further define keratinocyte binding regions within laminin, a 440-kD proteolytic fragment of laminin was generated by limited chymotrypsin digestion, which renders laminin devoid of all terminal globular domains. Substrata coated with this 440-kD laminin fragment did not promote keratinocyte adhesion, suggesting that the globular domains may play an important role in cell adhesion. Based on these experiments, a series of chemically synthesized peptides derived from the A or B1 chains of laminin were studied. Among these, three peptides were found to be active in directly promoting keratinocyte adhesion: peptide F-9 (RYVVLPRPVCFEK) from the inner globule of the human B1 chain, TG-1 (RPVRHAQCRVCDGNSTNPRERH) from the top globule of the amino terminus (short arm) of the A chain, and GD-6 (KQNCLSSRASFRGCVRNLRLSR) from the large carboxy terminal globule at the end of the long arm of the A chain. In competition assays, these peptides in solution were shown to inhibit laminin-mediated keratinocyte adhesion. These studies show that normal human keratinocytes bind directly to laminin at a minimum of three distinct sites.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2056184     DOI: 10.1111/1523-1747.ep12479311

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Integrin alpha 3 beta 1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells.

Authors:  P J Coopman; D M Thomas; K R Gehlsen; S C Mueller
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

2.  CD44/chondroitin sulfate proteoglycan and alpha 2 beta 1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes.

Authors:  J R Knutson; J Iida; G B Fields; J B McCarthy
Journal:  Mol Biol Cell       Date:  1996-03       Impact factor: 4.138

3.  Regulation of human nucleus pulposus cells by peptide-coupled substrates.

Authors:  Devin T Bridgen; Bailey V Fearing; Liufang Jing; Johannah Sanchez-Adams; Megan C Cohan; Farshid Guilak; Jun Chen; Lori A Setton
Journal:  Acta Biomater       Date:  2017-04-20       Impact factor: 8.947

4.  Expression of alpha 6 and beta 4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin.

Authors:  A P Skubitz; R C Bast; E A Wayner; P C Letourneau; M S Wilke
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

5.  The dermal-epidermal junction of human skin contains a novel laminin variant.

Authors:  M P Marinkovich; G P Lunstrum; D R Keene; R E Burgeson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

6.  A synthetic peptide derived from the carboxy terminus of the laminin A chain represents a binding site for the alpha 3 beta 1 integrin.

Authors:  K R Gehlsen; P Sriramarao; L T Furcht; A P Skubitz
Journal:  J Cell Biol       Date:  1992-04       Impact factor: 10.539

7.  Laminin mediates tissue-specific gene expression in mammary epithelia.

Authors:  C H Streuli; C Schmidhauser; N Bailey; P Yurchenco; A P Skubitz; C Roskelley; M J Bissell
Journal:  J Cell Biol       Date:  1995-05       Impact factor: 10.539

8.  Synthetic peptides from the carboxy-terminal globular domain of the A chain of laminin: their ability to promote cell adhesion and neurite outgrowth, and interact with heparin and the beta 1 integrin subunit.

Authors:  A P Skubitz; P C Letourneau; E Wayner; L T Furcht
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.